Professional Documents
Culture Documents
Endocrine disorders
Cushing syndrome
Hyperparathyroidis
Diabetes mellitus m Hyperthyroidism
Acromegaly Hypogonadism
Adrenal insufficiency Pregnancy
Estrogen deficiency Prolactinoma
Deficiency states
Calcium deficiency
Magnesium deficiency Gastrectomy
Protein deficiency Malabsorption
Vitamin D deficiency Malnutrition
Bariatric surgery Parenteral nutrition
Celiac disease Primary biliary cirrhosis
Inflammatory diseases
Inflammatory bowel disease
Ankylosing spondylitis Rheumatoid arthritis
Systemic lupus erythematosus
Hematologic and neoplastic disorders
Hemochromatosis
Hemophilia Sickle cell anemia
Leukemia Systemic mastocytosis
Lymphoma Thalassemia
Multiple myeloma Metastatic disease
Medications
Anticonvulsants
Antipsychotic drugs Furosemide
Antiretroviral drugs Glucocorticoids and corticotropin
Aromatase inhibitors Heparin (long term)
Chemotherapeutic/transplant Hormonal/endocrine therapies: gonadotropin-
drugs: cyclosporine, releasing hormone (GnRH) agonists, luteinizing
tacrolimus, platinum hormone-releasing hormone (LHRH)
compounds, analogues, depomedroxyprogesterone,
cyclophosphamide, excessive thyroxine
ifosfamide, high-dose Lithium
methotrexate Selective serotonin reuptake inhibitors (SSRIs)
Miscellaneous
Alcoholism
Amyloidosis Idiopathic scoliosis
Chronic metabolic acidosis Immobility
Congestive heart failure Multiple sclerosis
Depression Ochronosis
Emphysema Organ transplantation
Chronic or end-stage renal disease Pregnancy/lactation
Chronic liver disease Sarcoidosis
HIV/AIDS Weightlessness
Risk factors
Advanced age (≥50 years) Physical inactivity or immobilization
Female sex Use of certain drugs (eg,
White or Asian ethnicity anticonvulsants, systemic steroids,
Genetic factors, such as a family thyroid supplements, heparin,
history of osteoporosis chemotherapeutic agents, insulin)
Thin build or small stature, eg, body Alcohol and tobacco use
weight less than 127 lb, (57.7 kg) Androgen or estrogen deficiency
Amenorrhea Calcium deficiency
Late menarche Dowager hump
Early menopause
Postmenopausal
state
A potentially useful mnemonic for osteoporotic risk factors is
OSTEOPOROSIS, as follows:
• L O w calcium intake
• S eizure meds (anticonvulsants)
• T hin build
• E thanol intake
• Hyp O gonadism
• P revious fracture
• Thyr O id excess
• R ace (white, Asian)
• O ther relatives with osteoporosis
• S teroids
• I nactivity
• S moking
Epidemiology
• Women age 65 years and older and men age 70 years and
older, regardless of clinical risk factors
• Postmenopausal women and men above age 50–69, based
alpha-hydroxylase
on risk factor profile
• Postmenopausal women and men age 50 and older who
have had an adult-age fracture, to diagnose and determine
the degree of osteoporosis
• Vertebral imaging is recommended for the
following patients:
• All women age 70 and older and all men age 80 and older
whose BMD T-score at the spine, total hip, or femoral neck
is –1.0 or lower
• All women age 65 to 69 and all men age 70-79 whose BMD
T-score at the spine, total hip, or femoral neck is –1.5 or
lower
• Vertebral imaging is also recommended for
postmenopausal women and men age 50 and older with
the following specific risk factors:
• Low-trauma fractures
• Height loss of 1.5 inches (4 cm) or more since peak height at
age 20
• Height loss of 0.8 inches (2 cm) or more since a previously
documented height measurement
• Recent or ongoing long-term glucocorticoid treatment
• Other plain radiography features and recommended as follows:
- Obtain radiographs of the affected area in symptomatic patients
-Lateral spine radiography can be performed in asymptomatic
patients in whom a vertebral fracture is suspected; a scoliosis
series is useful for detecting occult vertebral fractures
-Radiographic findings can suggest the presence of osteopenia,
or bone loss, but cannot be used to diagnose osteoporosis
-Radiographs may also show other conditions, such as
osteoarthritis, disk disease, or spondylolisthesis
Diagnostic Considerations
• Osteomalacia
• Leukemia
• Lymphoma
• Metastases (bony and other)
• Pathologic fractures secondary to bone metastases from
cancer
• Pediatric osteogenesis imperfecta
• Renal osteodystrophy
Differential Diagnoses
• Homocystinuria/Homocysteinemia
• Hyperparathyroidism
• Imaging in Osteomalacia and Renal Osteodystrophy
• Mastocytosis
• Multiple Myeloma
• Paget Disease
• Scurvy
• Sickle Cell Anemia
Complications
• Vertebral compression fractures often occur with minimal
stress, such as coughing, lifting, or bending.
• Hip fractures are the most devastating and occur most
commonly at the femoral neck and intertrochanteric regions.
• Secondary complications of hip fractures include nosocomial
infections and pulmonary thromboembolism.
• Increased morbidity and mortality secondary to vertebral
compression fractures and hip fractures.
• Spinal deformities and a dowager's hump, and they may lose
1-2 inches of height by their seventh decade of life
Prognosis
Low bone mass BMD 1–2.5 SD below the mean for T-score between –1
(osteopenia) young-adult women and –2.5
Osteoporosis BMD ≥2.5 SD below the normal mean T-score ≤ –2.5
for young-adult women
BMD ≥2.5 SD below the normal mean
Severe or for young-adult women in a patient
T-score ≤ –2.5 (with
“established who has already experienced ≥1 fragility fracture[s])
” fractures
osteoporosis
Magnetic Resonance Imaging